Inclusion Criteria:  Male or female aged 60-80 years diagnosed with ischemic stroke acute or subacute phase The patient has had a CT scan/MRI of the brain to assess ischemic territory The patient must have an NIH Stroke score of 8-20 The patient or legal assistant has obtained detailed informed consent regarding the study protocol and agreeing to participate in the study Patients with The Glasgow Coma Scale (GCS) score > 8 Patients with Pt-APTT values within normal limits  Exclusion Criteria:  Patients with recurrent stroke in the 6 months preceding the episode current stroke CT or MRI images show midline shift and bleeding transformation Participate in similar studies using CM and/or UC-MSC Patients who are immunocompromised and/or who are receiving therapy immunosuppressive Patients who cannot have a CT or MRI examination due to their condition Patients with impaired renal and hepatic function after the onset of ischemic stroke: Serum Glutamic Oxaloacetic Transaminase (SGOT) and Serum Glutamic Pyruvic Transaminase (SGPT) > 5x the upper limit of normal values and a significant increase in urea-creatinine values Patients with a history of malignant tumors or other severe neurologic conditions.